Hyaluronic acid (HA) injection, also known as intra-articular hyaluronic acid injection, involves using a needle to inject a gel-like substance between the bones of the joints. The idea is to replace the naturally occurring hyaluronic aid that is depleted as cartilage wears down with time or after an injury—the most common causes of osteoarthritis (OA).
Also known as viscosupplementation, treating knee arthritis with HA injections aims to improve lubrication within the joint in order reduce pain and improve ease and range of motion. Before you consider this treatment, discuss it thoroughly with your rheumatologist, as there are some important things you should know before you agree to have it. Lip Injection Extreme
In 2019 the American College of Rheumatology (ACR) and the Arthritis Foundation (AF) conditionally recommended against treating knee arthritis with intra-articular hyaluronic acid in guidelines for managing OA of the knee, hip, and hand. Similarly, the American Academy of Orthopedic Surgeons does not recommend HA injections for knee arthritis.
This is largely because while replacing lost hyaluronic acid may sound like an easy fix for OA, research has not found this to be the case. In studies comparing hyaluronic acid injections to a placebo (saline injections), the hyaluronic acid has been no more effective than the saline.
Similarly, there is no definitive answer to whether hyaluronic acid injections are any more effective than corticosteroid injections or oral medications. This doesn't necessarily mean you won't be helped with this treatment, but based on studies it's possible you won't.
Your healthcare provider may want to try hyaluronic acid for you knee OA, but only after more effective treatments haven't relieved symptoms enough. This can be tricky because research has shown that if hyaluronic acid is at all beneficial, the best results usually occur during the early stages of OA.
For treating knee OA, the ACR/AF guidelines strongly recommend other specific approaches: topical and oral non-steroidal anti-inflammatory drugs (NSAIDs) and steroid injections as well as a number of non-medical management strategies such as weight loss, exercise or physical therapy, tai chi, hot or cold therapy, and use of a cane.
Hyaluronic injections typically are not considered unless pain relief medications and steroid injections do not relieve symptoms or become less effective after working for some time.
Conditionally recommended treatments for knee OA are topical capsaicin (in over-the-counter products such as Aspercreme and Zostrix HP) and OTC and prescription oral medications including acetaminophen (the active ingredient in Tylenol), Cymbalta (duloxetine,) and Conzipor or Qdolo (tramadol).
The most significant pain relief from knee osteoarthritis tends to occur eight and 12 weeks after the first injection and can last up to six months or even longer.
Interestingly, the Food and Drug Administration (FDA) regards hyaluronic acid injections as class III medical devices, defined as those that "sustain or support life, are implanted, or present reasonable risk of illness or injury." Examples of other class III devices are breast implants and pacemakers.
However, there is some discussion of reclassifying hyaluronic acid injections as drugs, as research has shown they work primarily "through chemical action in the body."
Two types of HA are used in intra-articular knee injections: one is derived from rooster combs, while the other is created in the lab using a process that involves bacterial formation. This is important to know if you happen to be allergic to avian (bird) products such as feathers, eggs, or poultry, in which case you could have a serious allergic reaction to any of the hyaluronic acid brands made from rooster combs.
There are eight brands of hyaluronic acid approved by the FDA for treating knee osteoarthritis. Besides how they're made, each differs in how it's administered and how quickly it tends to bring relief. According to the manufacturers, all are effective for up to six months.
As with any medical treatment, there's a possibility you'll experience side effects after receiving an injection of hyaluronic acid. The most common ones affect the injection site, including:
These tend to be temporary and mild. You can reduce the chances of experiencing side effects by avoiding strenuous activities and resting your knee for the first 48 hours following your injection.
Neither type of hyaluronic acid injections are considered safe for children, pregnant women, and nursing mothers. It's important that your healthcare provider has your complete medical history before they suggest or administer hyaluronic acid to treat knee OA.
If you're taking medication for pain or inflammation of your knee OA at the time of your injection, it's good to know that there should be no adverse interactions between them and the hyaluronic acid. Confirm this with your healthcare provider, but you should not have to stop taking your regular medication.
The FDA has approved hyaluronic acid injections for osteoarthritis of the knee only—not for OA that affects any other joints.
In part because the AAOS does not recommend hyaluronic acid injections for knee OA, there's a strong possibility your insurance company will not cover it. If not, it's important to know the procedure can be quite expensive: A course of three injections of Synvisc, for example, can cost as much as $1,600.
Medicare will cover HA injections for the knee, but you'll likely have to provide documentation or X-ray evidence to prove it's needed first. Both Medicare and private insurance typically will approve hyaluronic acid injections no more often than every six months.
Guo Y, Yang P, Liu L. Origin and efficacy of hyaluronan injections in knee osteoarthritis: Randomized, double-blind trial. Med Sci Monit. 2018;24:4728–4737. doi:10.12659/MSM.908797
Kolasinski SL, Neogi T, Hochberg MC, et al. American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care & Research. Feb 2020;72(2):149-162. doi:10.10002/acr.24131
American Academy of Orthopedic Surgeons. Treatment of Osteoarthritis of the Knee, 2nd edition.
Rutjes AWS, Juni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-anlaysis. Ann Intern Med. 2012 Aug 7;157(3):180-91. doi:10.7326/0003-4819-157-3-201208070-00473
Askari A, Gholami T, NaghiZadeh MM, et al. Hyaluronic acid compared with corticosteroid injections for the treatment of osteoarthritis of the knee: a randomized control trial. Springerplus. 2016;5:442. doi:10.1186/s40064-016-2020-0
Bhadra AK, Altman R, Dasa V, et al. Appropriate use criteria for hyaluronic acid in the treatment of knee osteoarthritis in the United States. Cartilage. 2017;8(3):234–254. doi:10.1177/1947603516662503
Bowman S, Awad ME, Hamrick MW, et al. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Transl Med. Feb 16 2018;7(1):6. doi:10.1186/s40169-017-0180-3
Allen C, Sheehan R, Deyle G, et al. A manual physical therapy intervention for symptoms of knee osteoarthritis and associated fall risk: A case series of four patients. Physiother Theory Pract. 2019;35(4):392-400. doi:10.1080/09593985.2018.1443360
Bronstone A, Neary JT, Lambert TH, et al. Supartz (sodium hyaluronate) for the treatment of knee osteoarthritis: A review of efficacy and safety. Clin Med Insights Arthritis Musculoskelet Disord. 2019;12:1179544119835221. doi:10.1177/1179544119835221
Food and Drug Administration. Learn If a Medical Device Has Been Cleared by FDA for Marketing.
Regulatory Focus. FDA Floats Regulating Hyaluronic Acid Products as Drugs, Not Devices.
Yoshioka K, Katayama M, Nishiyama T, et al. Biocompatibility study of different hyaluronan products for intra-articular treatment of knee osteoarthritis. BMC Musculoskelet Disord. 2019;20(1):424. doi:10.1186/s12891-019-2815-6
Arthritis Foundation. Hyaluronic Acid for Osteoarthritis.
Walker K, Basehore BM, Zito PM. Hyaluronic Acid. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
Altman RD, Akermark C, Beaulieu AD, et al. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthr Cartil. 2004;12(8):642-9. doi:10.1016/j.joca.2004.04.010
Euppayo T, Punyapornwithaya V, Chomdej S, et al. Effects of hyaluronic acid combined with anti-inflammatory drugs compared with hyaluronic acid alone, in clinical trials and experiments in osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2017;18(1):387. doi:10.1186/s12891-017-1743-6
Vangsness CT, Adamson TC, Daley MJ. Consequences of private insurance coverage: The AAOS clinical practice guidelines and hyaluronic acid injections. J Bone Joint Surg Am. 2020 May 20; 102(10): 920–926. doi:10.2106/JBJS.19.00272
Centers for Medicare & Medicaid Services. Local Coverage Determination (LCD): Hyaluronan Acid Therapies for Osteoarthritis.
Kaulback K, Jones S, Wells C, Felipe E. Viscosupplementation for knee osteoarthritis: A review of clinical and cost-effectiveness and guidelines [internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. CADTH Rapid Response Reports.
Wang SZ, Wu DY, Chang Q, et al. Intra-articular, single-shot co-injection of hyaluronic acid and corticosteroids in knee osteoarthritis: A randomized controlled trial. Exp Ther Med. 2018 Sep;16(3):1928-1934. doi: 10.3892/etm.2018.6371. Epub 2018 Jun 29. doi:/10.3892/etm.2018.6371
By Carol Eustice Carol Eustice is a writer who covers arthritis and chronic illness. She is the author of "The Everything Health Guide to Arthritis."
Thank you, {{form.email}}, for signing up.
There was an error. Please try again.
Hair Stem Cell By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.